Volume | 250,580 |
|
|||||
News | - | ||||||
Day High | 0.64 | Low High |
|||||
Day Low | 0.5409 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
IM Cannabis Corporation | IMCC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.5677 | 0.5409 | 0.64 | 0.5548 | 0.5668 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
711 | 250,580 | US$ 0.5792193 | US$ 145,141 | - | 0.189 - 1.43 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:33:38 | 1 | US$ 0.53 | USD |
IM Cannabis Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.23M | 13.39M | - | 48.8M | -9.5M | -0.71 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
IM Cannabis News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMCC Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.5689 | 0.6499 | 0.51 | 0.5728357 | 113,015 | -0.0189 | -3.32% |
1 Month | 0.5536 | 1.35 | 0.50 | 0.8531119 | 989,930 | -0.0036 | -0.65% |
3 Months | 0.272 | 1.35 | 0.235 | 0.6475924 | 595,805 | 0.278 | 102.21% |
6 Months | 0.51 | 1.35 | 0.189 | 0.5614183 | 379,591 | 0.04 | 7.84% |
1 Year | 0.66 | 1.43 | 0.189 | 0.608881 | 221,256 | -0.11 | -16.67% |
3 Years | 70.00 | 70.00 | 0.189 | 15.14 | 233,484 | -69.45 | -99.21% |
5 Years | 86.50 | 116.30 | 0.189 | 15.69 | 224,084 | -85.95 | -99.36% |
IM Cannabis Description
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. |